An arylvinylazacycloalkane comound
PK140771AUndetermined Publication Date: 2010-06-02TARGACEPT INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200400158
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-06-02
Abstract
A compound of Formula (I) is disclosed. The compound is a ligand of various nAChRs. The compound can be used to prepare pharmaceutical composition and / or medicament intended to prevent or treat disorders associated with dysfunction of nAChRs, especially within the central nervous system or the gastrointestinal system. Examples of types of disorders that can be treated include neurodegenerative disorders, including central nervous system disorders such as Alzheimer's disease, cognitive disorders, motor disorders such as Parkinson's disease, drug addiction, behavioral disorders and inflammatory disorders within the gastrointestinal system. The compound can also serve as analgesics in the treatment of acute, chronic or recurrent pain.
Need to check novelty before this filing date? Find Prior Art